169 related articles for article (PubMed ID: 6728045)
21. Captopril and the intestinal response to hemorrhagic shock.
Rosenfeld LM; Cooper HS
Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):144-52. PubMed ID: 6758718
[TBL] [Abstract][Full Text] [Related]
22. Salutary consequences of blockade of platelet activating factor in hemorrhagic shock.
Stahl GL; Bitterman H; Terashita Z; Lefer AM
Eur J Pharmacol; 1988 May; 149(3):233-40. PubMed ID: 3409951
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic hypoperfusion and the production of a myocardial depressant factor in hemorrhagic shock.
Lefer AM; Spath JA
Ann Surg; 1974 Jun; 179(6):868-76. PubMed ID: 4835505
[TBL] [Abstract][Full Text] [Related]
24. Use of the novel cardiotonic and vasodilator agent pimobendan in traumatic shock.
Bitterman H; Smith BA; Lefer AM
Arzneimittelforschung; 1988 Oct; 38(10):1389-93. PubMed ID: 3196378
[TBL] [Abstract][Full Text] [Related]
25. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
Bitterman H; Smith BA; Lefer AM
Circ Shock; 1988 Mar; 24(3):159-68. PubMed ID: 3383353
[TBL] [Abstract][Full Text] [Related]
26. Novel mechanism of action of a prostacyclin enhancing agent in haemorrhagic shock.
Bitterman H; Lefer DJ; Lefer AM
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):679-86. PubMed ID: 3063971
[TBL] [Abstract][Full Text] [Related]
27. [Dopaminergic effect of anisodamine on the microcirculation of the hydronephrotic kidney of rats].
Zou AP; Parekh N; Steinhausen M
J Tongji Med Univ; 1991; 11(2):65-72. PubMed ID: 1687750
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of action of PGE1 in hemorrhagic shock in rats.
Bitterman H; Stahl GL; Terashita Z; Lefer AM
Ann Emerg Med; 1988 May; 17(5):457-62. PubMed ID: 3364825
[TBL] [Abstract][Full Text] [Related]
29. Combined administration of anisodamine and neostigmine produces anti-shock effects: involvement of α7 nicotinic acetylcholine receptors.
Sun L; Zhang GF; Zhang X; Liu Q; Liu JG; Su DF; Liu C
Acta Pharmacol Sin; 2012 Jun; 33(6):761-6. PubMed ID: 22580739
[TBL] [Abstract][Full Text] [Related]
30. Amelioration of splanchnic artery occlusion (SAO) shock by cysteine.
Galvin MJ; Lefer AM
Adv Shock Res; 1978; 1():261-70. PubMed ID: 262085
[No Abstract] [Full Text] [Related]
31. Arachidonic acid in splanchnic artery occlusion shock.
Bridenbaugh GA; Flynn JT; Lefer AM
Am J Physiol; 1976 Jul; 231(1):112-9. PubMed ID: 961849
[TBL] [Abstract][Full Text] [Related]
32. Potentiation of the protective effects of a converting enzyme inhibitor and a thromboxane synthetase inhibitor in hemorrhagic shock.
Bitterman H; Phillips GR; Dragon G; Lefer AM
J Pharmacol Exp Ther; 1987 Jul; 242(1):8-14. PubMed ID: 3039116
[TBL] [Abstract][Full Text] [Related]
33. [The effect of anisodamine on lipoprotein metabolism in the liver and the plasma membrane phospholipids of the hepatocytes in hemorrhagic shock].
Leskova GF; Su LB; Udovichenko VI
Patol Fiziol Eksp Ter; 1990; (1):15-7. PubMed ID: 2352771
[TBL] [Abstract][Full Text] [Related]
34. Enteric administration of anisodamine in the treatment of hemorrhagic shock.
Su JY; Hock CE; Lefer AM
Acta Acad Med Wuhan; 1985; 5(2):92-6. PubMed ID: 4022545
[No Abstract] [Full Text] [Related]
35. Beneficial effects of transforming growth factor-beta and tissue plasminogen activator in splanchnic artery occlusion and reperfusion in cats.
Karasawa A; Guo JP; Ma XL; Lefer AM
J Cardiovasc Pharmacol; 1991 Jul; 18(1):95-105. PubMed ID: 1719297
[TBL] [Abstract][Full Text] [Related]
36. Shock potentiating actions of angiotensin II infusion in cats.
Trachte GJ; Lefer AM
Circ Shock; 1980; 7(3):343-51. PubMed ID: 7449049
[TBL] [Abstract][Full Text] [Related]
37. Studies on cellular mechanism of the antishock action of anisodamine in rats--effect of anisodamine on the stability of liver lysosomes and comparison of its membrane-stabilizing action with that of dexamethasone.
Zhu Y; Su JY
J Tongji Med Univ; 1986; 6(4):221-7. PubMed ID: 3806741
[No Abstract] [Full Text] [Related]
38. Protective effect of cloricromene, a coumarine derivative, in hypovolemic hemorrhagic shock in the rat.
Sturniolo R; Squadrito F; Campo GM; Vinci R; Calatroni A; Prosdocimi M; Caputi AP
J Cardiovasc Pharmacol; 1991 Feb; 17(2):261-6. PubMed ID: 1709231
[TBL] [Abstract][Full Text] [Related]
39. Protective effects of CG-4203, a novel stable prostacyclin analog, in traumatic shock.
Bitterman H; Stahl GL; Lefer AM
Prostaglandins; 1988 Jan; 35(1):41-50. PubMed ID: 3287456
[TBL] [Abstract][Full Text] [Related]
40. Effect of suppression of endocrine or exocrine pancreatic function in hemorrhagic shock.
Galvin MJ; Lefer AM
Experientia; 1979 Jan; 35(1):55-6. PubMed ID: 369876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
